MedTrace Logo

Repeated Low-Level Red-Light Therapy and Orthokeratology in Fast-progressing Myopia Control

NCT04722874 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2021-08-13

No results posted yet for this study

Summary

The purpose of this multicenter randomized clinical trial is to evaluate the adjunctive effect of repeated low-level red-light therapy (RLRL) and orthokeratology (ortho-k) on myopia control in ortho-k non-responders who have undergone ortho-k treatment but were still experiencing fast myopia progression.

Conditions

  • Myopia, Progressive
  • Refractive Errors
  • Eye Diseases

Interventions

DEVICE

Ortho-k lenses

Ortho-k lenses will be administered nightly.

DEVICE

RLRL

RLRL will be performed twice a day with an interval of at least 4 hours, each treatment last 3 minutes. Nightly treatment should be performed at least 30 minutes before ortho-k lens insertion.

Sponsors & Collaborators

  • The Second People's Hospital of Foshan

    collaborator OTHER

  • Tianjin Medical University Eye Center

    collaborator UNKNOWN

  • Zhongshan Ophthalmic Center, Sun Yat-sen University

    lead OTHER

Principal Investigators

  • Xiao Yang, Professor · Zhongshan Ophthalmic Center, Sun Yat-sen University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
13 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-14
Primary Completion
2022-06-30
Completion
2022-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04722874 on ClinicalTrials.gov